Screener
Amphastar Pharmaceuticals AMPH Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's net debt?
- Amphastar Pharmaceuticals (AMPH) reported net debt of $464.9M in Q2 2026.
- How has Amphastar Pharmaceuticals's net debt changed year-over-year?
- Amphastar Pharmaceuticals's net debt decreased by 0.7% year-over-year, from $468.15M to $464.9M.
- What is the long-term trend for Amphastar Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's net debt has grown at a 81.3% compound annual growth rate (CAGR), from -$24.85M to $486.09M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Amphastar Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude